FR2441616B1 - Nouvel imidazole, procede pour sa preparation et son application therapeutique - Google Patents
Nouvel imidazole, procede pour sa preparation et son application therapeutiqueInfo
- Publication number
- FR2441616B1 FR2441616B1 FR7928099A FR7928099A FR2441616B1 FR 2441616 B1 FR2441616 B1 FR 2441616B1 FR 7928099 A FR7928099 A FR 7928099A FR 7928099 A FR7928099 A FR 7928099A FR 2441616 B1 FR2441616 B1 FR 2441616B1
- Authority
- FR
- France
- Prior art keywords
- preparation
- therapeutic application
- novel imidazole
- imidazole
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13932578A JPS5566562A (en) | 1978-11-14 | 1978-11-14 | Novel imidazole derivative and antidepressant containing the same |
JP14281378A JPS5569567A (en) | 1978-11-21 | 1978-11-21 | Novel imidazole compound, and antidepressant containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2441616A1 FR2441616A1 (fr) | 1980-06-13 |
FR2441616B1 true FR2441616B1 (fr) | 1986-05-09 |
Family
ID=26472162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7928099A Expired FR2441616B1 (fr) | 1978-11-14 | 1979-11-14 | Nouvel imidazole, procede pour sa preparation et son application therapeutique |
Country Status (9)
Country | Link |
---|---|
US (4) | US4301169A (fr) |
CA (1) | CA1126272A (fr) |
CH (1) | CH642635A5 (fr) |
DE (1) | DE2946020A1 (fr) |
FR (1) | FR2441616B1 (fr) |
GB (1) | GB2044754B (fr) |
IT (1) | IT1127223B (fr) |
NL (1) | NL7908331A (fr) |
SE (1) | SE447653B (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE447653B (sv) * | 1978-11-14 | 1986-12-01 | Eisai Co Ltd | Imidazolderivat samt farmaceutisk komposition innehallande sadant derivat |
US4353905A (en) * | 1981-09-17 | 1982-10-12 | Warner-Lambert Company | Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones |
US5138069A (en) * | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
CA1334092C (fr) * | 1986-07-11 | 1995-01-24 | David John Carini | Imidazoles bloquant les recepteurs de l'angiotensine ii |
US4851526A (en) * | 1987-09-04 | 1989-07-25 | Schering A.G. | 1-(4-Substituted phenyl)-1H-imidazoles compounds |
US5210079A (en) * | 1988-01-07 | 1993-05-11 | E. I. Du Pont De Nemours And Company | Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists |
DE122007000050I1 (de) * | 1990-02-19 | 2007-11-08 | Novartis Ag | Acylverbindungen |
MY106533A (en) * | 1990-02-20 | 1995-06-30 | Sumitomo Chemical Co | A 4-tert.-butyl imidazole derivative and its production and use. |
US5140037A (en) * | 1990-03-20 | 1992-08-18 | E. I. Du Pont De Nemours And Company | Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists |
US5179113A (en) * | 1990-03-20 | 1993-01-12 | E. I. Du Pont De Nemours And Company | Treatment of central nervous disorders with imidazole compounds |
US5137906A (en) * | 1990-03-20 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Treatment of central nervous system disorders with benzimidazole angiotensin-II receptor antagonists |
US5173494A (en) * | 1990-03-20 | 1992-12-22 | E. I. Du Pont De Nemours And Company | Specific inhibition of angiotensin-II binding to angiotensin-II receptor subtype-2 |
US5155126A (en) * | 1990-03-20 | 1992-10-13 | E. I. Du Pont De Nemours And Company | Treatment of central nervous system disorders with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists |
CA2036148A1 (fr) * | 1990-06-29 | 1991-12-30 | Hiroki Tomioka | Derive de 1-phenylimidazole ainsi que sa production et son utilisation |
US6008368A (en) * | 1993-04-28 | 1999-12-28 | G. D. Searle & Co. | Pharmaceutical compositions for treatment of circulatory disorders using N-substituted (α-imidazolyl-toluyl) pyrrole aniotensin II antagonists |
US5187271A (en) * | 1991-02-28 | 1993-02-16 | G. D. Searle & Co. | N-substituted (α-imidazolyl-toluyl) pyrrole compounds for treatment of circulatory disorders |
US5451597A (en) * | 1993-05-27 | 1995-09-19 | G.D. Searle & Co. | Treatment of circulatory disorders using n-substituted (α-imidazolyl-toluyl) pyrrole angiotensin II antagonists |
AU2352295A (en) * | 1994-04-27 | 1995-11-16 | Nippon Soda Co., Ltd. | Imidazole derivative and process for producing the same |
CA2339123A1 (fr) | 1998-07-31 | 2000-02-10 | Nippon Soda Co., Ltd. | Composes phenylazole, procede de production desdits composes et medicaments pour le traitement de l'hyperlipidemie |
AUPQ319899A0 (en) * | 1999-10-01 | 1999-10-28 | Fujisawa Pharmaceutical Co., Ltd. | Amide compounds |
US6627647B1 (en) | 2000-03-23 | 2003-09-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted 1-(4-aminophenyl)imidazoles and their use as anti-inflammatory agents |
JP4377881B2 (ja) * | 2003-08-01 | 2009-12-02 | 日本曹達株式会社 | フェニルアゾール化合物、製造法および抗酸化薬 |
KR101292598B1 (ko) * | 2005-01-14 | 2013-08-05 | 질레드 코네티컷 인코포레이티드 | 키나아제 활성 조절제로서의 1,3-디아릴 치환된 우레아 |
US7625931B2 (en) * | 2005-01-14 | 2009-12-01 | Cgi Pharmaceuticals, Inc. | Certain substituted diphenyl ureas, as modulators of kinase activity |
WO2007024294A2 (fr) * | 2005-05-03 | 2007-03-01 | Cgi Pharmaceuticals, Inc. | Certains urees substitues, modulateurs de l'activite des kinases |
EP2066642A1 (fr) * | 2006-09-25 | 2009-06-10 | Arete Therapeutics, INC. | Inhibiteurs d'époxyde hydrolase soluble |
WO2008051875A2 (fr) * | 2006-10-20 | 2008-05-02 | Arete Therapeutics, Inc. | Inhibiteurs d'époxyde hydrolase soluble |
AU2013309002B2 (en) | 2012-08-28 | 2016-05-26 | 3M Innovative Properties Company | Chlorhexidine gluconate compositions, resin systems and articles |
WO2019194220A1 (fr) * | 2018-04-06 | 2019-10-10 | 日本曹達株式会社 | Composé (hétéro)arylsulfonamide et agent de lutte contre les organismes nuisibles |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1578644A (fr) * | 1967-09-02 | 1969-08-14 | ||
US3637731A (en) * | 1968-07-18 | 1972-01-25 | Du Pont | 1-(alkylsubstituted phenyl)imidazoles useful in acth reserve assay |
US4172947A (en) * | 1977-01-07 | 1979-10-30 | Westwood Pharmaceuticals, Inc. | 1-(2-Acylaminophenyl)imidazoles |
US4284641A (en) * | 1977-08-26 | 1981-08-18 | Burroughs Wellcome Co. | Pharmaceutically active imidazole derivatives |
US4431815A (en) * | 1977-08-26 | 1984-02-14 | Burroughs Wellcome Co. | 1-[3-(2,4-Dichlorophenyl)propyl]imidazole and salts thereof |
SE447653B (sv) * | 1978-11-14 | 1986-12-01 | Eisai Co Ltd | Imidazolderivat samt farmaceutisk komposition innehallande sadant derivat |
-
1979
- 1979-11-13 SE SE7909371A patent/SE447653B/sv not_active IP Right Cessation
- 1979-11-13 GB GB7939283A patent/GB2044754B/en not_active Expired
- 1979-11-13 US US06/093,469 patent/US4301169A/en not_active Expired - Lifetime
- 1979-11-14 FR FR7928099A patent/FR2441616B1/fr not_active Expired
- 1979-11-14 CH CH1014979A patent/CH642635A5/fr not_active IP Right Cessation
- 1979-11-14 CA CA339,861A patent/CA1126272A/fr not_active Expired
- 1979-11-14 DE DE19792946020 patent/DE2946020A1/de not_active Withdrawn
- 1979-11-14 NL NL7908331A patent/NL7908331A/nl not_active Application Discontinuation
- 1979-11-14 IT IT27268/79A patent/IT1127223B/it active
-
1981
- 1981-04-09 US US06/252,674 patent/US4402966A/en not_active Expired - Fee Related
-
1983
- 1983-02-25 US US06/469,548 patent/US4533669A/en not_active Expired - Fee Related
-
1985
- 1985-06-06 US US06/741,935 patent/US4602031A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR2441616A1 (fr) | 1980-06-13 |
US4533669A (en) | 1985-08-06 |
DE2946020A1 (de) | 1980-05-29 |
CA1126272A (fr) | 1982-06-22 |
SE447653B (sv) | 1986-12-01 |
NL7908331A (nl) | 1980-05-19 |
US4402966A (en) | 1983-09-06 |
IT1127223B (it) | 1986-05-21 |
GB2044754B (en) | 1983-05-05 |
CH642635A5 (fr) | 1984-04-30 |
US4301169A (en) | 1981-11-17 |
SE7909371L (sv) | 1980-05-15 |
IT7927268A0 (it) | 1979-11-14 |
GB2044754A (en) | 1980-10-22 |
US4602031A (en) | 1986-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2441616B1 (fr) | Nouvel imidazole, procede pour sa preparation et son application therapeutique | |
BE876455A (fr) | Procede de therapeutique anxiolytique | |
FR2487353B1 (fr) | Derives d'hydantoine, leur procede de preparation et leur application therapeutique | |
BE878723A (fr) | Derives de 4-anilinoquinazoline, leur procede de preparation et leur application en therapeutique | |
BE875174A (fr) | Nouveaux derives de carbostyrile, leur procede de preparation et leurs applications en therapeutique | |
BE890331A (fr) | Maleate de 2-amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)pyridine, procede pour sa preparation et son application comme medicament | |
LU81482A1 (fr) | Procede de preparation de d-camphorate de l-carnitinamide et de d-camphorate de d-carnitinamide | |
BE851893A (fr) | Nouvelles aryl-3 oxazolidinones-2, leur procede de preparation et leur application en therapeutique | |
BE854268A (fr) | Pyrrolidones, leur procede de preparation et leur application therapeutique | |
FR2458547B2 (fr) | Nouvelles n-aryle azolones, leur procede de preparation et leur application en therapeutique | |
BE841747A (fr) | Ether 1,2,2,2,-tetrafluoroethyl-fluoromethylique, son procede de preparation et son application | |
BE854133A (fr) | 1,3-dihydro-heteroarylspito(isobenzofurannes)et leur procede de preparation et leur application therapeutique | |
FR2351965A1 (fr) | Benzenesulfonylurees, leur procede de preparation et leur application therapeutique | |
BE883713A (fr) | Nouveau derives de carbostyrile, leur procede de preparation et leur application en therapeutique | |
BE878127A (fr) | Amides 1,2,3-triazolecarboxyliques, leur procede de preparation et leur utilisation | |
BE880615A (fr) | Nouveau derive du paracetamol, son procede de preparation et son utilisation en therapeutique | |
BE861107A (fr) | P-isobutyl-hydratropate de gaiacol et procede pour sa preparation | |
MA18466A1 (fr) | Fongicides et procede pour leur preparation | |
BE880292A (fr) | Nouveaux acides oxy-cyclohexylacetiques substitues, leur procede de preparation et leur application en therapeutique | |
BE876909A (fr) | Sel sodique de mercaptopropionylglycine, procede pour sa preparation et utilisations therapeutiques | |
ZA79271B (en) | 1-naphthyl-acetic acid derivatives,process for their preparation and their therapeutic applications | |
FR2352776A1 (fr) | Solution sursaturee de dinitrate d'isosorbide, procede pour sa preparation et son application | |
OA06776A (fr) | Procédé de préparations pharmaceutiques. | |
BE880031A (fr) | Procede pour la preparation de 1 alpha, 3 beta-dihydroxy-delta 5-steroides | |
DE2962151D1 (en) | Bis-n-dialkylcarbamyl-quinacridones, process for their preparation and their application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |